| 摘要 |
Novel compounds of the formula (I), in which D, W, X, Y, T, m and R<SUP>1 </SUP>have the meaning indicated in Patent claim 1 , are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumour
|
